Back to REGN
KBC Group NV REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$1.8M
Q3 2026
Peak value
$141.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $29K |
| Q3 2025 | $18.6M |
| Q3 2025 | $82K |
| Q4 2025 | $40K |
| Q4 2025 | $29.3M |
| Q4 2025 | $147K |
| Q1 2026 | $40K |
| Q1 2026 | $29.5M |
| Q1 2026 | $148K |
| Q2 2026 | $32K |
| Q2 2026 | $110.7M |
| Q2 2026 | $1.2M |
| Q3 2026 | $39K |
| Q3 2026 | $141.1M |
| Q3 2026 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.8M | 2.3K | — | — |
| Q3 2026 | $141.1M | 186.1K | — | — |
| Q3 2026 | $39K | 52 | — | — |
| Q2 2026 | $1.2M | 1.9K | — | — |
| Q2 2026 | $110.7M | 177.5K | — | — |
| Q2 2026 | $32K | 52 | — | — |
| Q1 2026 | $148K | 191 | — | — |
| Q1 2026 | $29.5M | 38.2K | — | — |
| Q1 2026 | $40K | 52 | — | — |
| Q4 2025 | $147K | 191 | — | — |
| Q4 2025 | $29.3M | 38.0K | — | — |
| Q4 2025 | $40K | 52 | — | — |
| Q3 2025 | $82K | 146 | — | — |
| Q3 2025 | $18.6M | 33.1K | — | — |
| Q3 2025 | $29K | 52 | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B